Functional gonadotroph adenomas
Authors:
- Diane DoneganDDDiane Donegan
- Dana EricksonDEDana Erickson
- 13 August 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 33 (6) , 249-256
Abstract
Purpose of review: Functional gonadotroph tumors (FGTs) are rare tumors of the anterior pituitary gland which produce and secrete gonadotropins leading to symptoms. Given that these tumors are not common, there is limited information available regarding optimal management. Recent findings: Symptoms attributable to gonadotropin secretion are often nonspecific in men and is often underrecognized in women. Consequently, many patients present with symptoms related to tumor mass effect, including visual changes and/or headaches, and are subsequently – or retrospectively – recognized to have an FGT. Summary: A high level of clinical suspicion and thorough investigations will allow for detection of FGT. Like other pituitary tumors, surgery is the primary form of treatment. Although long-term follow-up data are limited given the rarity of this tumor, recurrence is reported and therefore long-term follow-up is necessary.Keywords
This publication has 26 references indexed in Scilit:
- Characterization of the secretory profile of gonadotroph pituitary tumorsJournal of Endocrinological Investigation, 2025
- Clinical features and literature review in children and adolescent patients with functioning gonadotroph pituitary neuroendocrine tumorsEndocrine, 2025
- Clinically Nonfunctioning Pituitary AdenomasEndocrinology and Metabolism Clinics of North America, 2025
- Diagnosis and Management of Pituitary AdenomasJAMA, 2023
- Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literaturePituitary, 2022
- Functioning gonadotroph adenoma with severe ovarian hyperstimulation syndrome: A new emergency in pituitary adenoma surgery? Surgical considerations and literature reviewAnnales d'Endocrinologie, 2019
- Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomasPituitary, 2017
- Testicular enlargement in a patient with a FSH-secreting pituitary adenomaEndocrine, 2010
- Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomasFertility and Sterility, 2006
- Diagnosis of pituitary gonadotroph adenomas in reproductive-aged womenFertility and Sterility, 2005